Patent ID: 11911509
Assignee: SYNTHON B.V.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A | IPC A

Claim 14:
15. A pharmaceutical composition, comprising, based on the total weight of the composition,
g) a therapeutically effective dose of lenvatinib mesylate in an amount of from 4% to 25% by weight;
h) microcrystalline cellulose in an amount of from 20% to 65% by weight;
i) sodium bicarbonate in an amount of from 20 to 55%;
j) optionally, low substituted hydroxypropyl cellulose in an amount of from 15% to 25% by weight;
k) mannitol in an amount of from 7% to 18% by weight; and
l) Talc in an amount of from 1% to 5% by weight;
wherein the weight ratio of Lenvatinib mesylate to sodium bicarbonate ranges from 1:1.5 to 1:5.